α/β-Hydrolase Domain Containing 5 Supports Glucose-Stimulated Lipolysis and Insulin Secretion in Pancreatic β-Cells
Diabetes · 01.08.2026 · 75 (8) · 1411-1423
DOI: 10.2337/db25-1156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 28.05.2026. Verfasst von Lucy Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA. Hauptthemen laut MEDLINE: Lipolysis, Insulin-Secreting Cells, Glucose, Insulin. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, BLRD VA, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Adipose triglyceride (TG) lipase (ATGL) is the rate-limiting enzyme of TG catabolism at the surface of lipid droplets (LDs). In pancreatic β-cells, lipolysis by ATGL increases with glucose and produces metabolites that support glucose-stimulated insulin secretion (GSIS). Upregulation of lipolysis by glucose is blunted in human islets affected by type 2 diabetes. However, how glucose regulates lipolysis in β-cells is unknown. We found that glucose recruits ATGL coactivator α/β-hydrolase domain containing 5 (ABHD5) to LDs in INS-1 cells and human β-cells. ABHD5 recruitment to LDs was reduced by inhibitors of cAMP-dependent protein kinase (PKA) or the expression of PKA-resistant mutant ABHD5, indicating that PKA phosphorylation contributes to ABHD5 recruitment to LDs. Importantly, ABHD5 was indispensable for glucose-stimulated lipolysis in INS-1 cells and human β-cells. ABHD5 knockdown increased LDs and TG content in INS-1 cells and human islets, indicating that ABHD5 is a critical regulator of ATGL activity in β-cells. Additionally, GSIS was impaired in ABHD5-downregulated INS-1 cells and human pseudoislets, which agrees with a role of ATGL in supporting GSIS in β-cells. Thus, ABHD5 plays an important role in conferring glucose responsiveness in lipolysis and supporting insulin secretion in β-cells. Article Highlights Lipolysis is stimulated by glucose and supports glucose-stimulated insulin secretion in pancreatic β-cells. However, the mechanism by which glucose increases lipolysis in β-cells is unknown. We aimed to identify a glucose-responsive regulator of lipolysis in β-cells. Glucose promotes α/β-hydrolase domain containing 5 (ABHD5) recruitment to lipid droplets where lipolysis occurs, which is at least partially mediated by cAMP-dependent kinase A. ABHD5 is required for glucose-stimulated lipolysis and insulin secretion. ABHD5 is a potential target to restore glucose-stimulated lipolysis in β-cells affected by type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.
- Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA.
- Veterans Affairs Iowa City Medical Center, Iowa City, IA.
ORCID-Profile: Siming Liu, Yumi Imai
Förderung
- NIDDK NIH HHS
- BLRD VA
- U.S. Department of Veterans Affairs
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Kim, L., Liu, S., Peachee, S., Richtsmeier, S., Jun, C., Sagona, G., Vikram, A., Freshly, A., Haider, F., & Imai, Y. (2026). α/β-Hydrolase Domain Containing 5 Supports Glucose-Stimulated Lipolysis and Insulin Secretion in Pancreatic β-Cells. Diabetes, 75(8), 1411-1423. https://doi.org/10.2337/db25-1156
Vancouver
Kim L, Liu S, Peachee S, Richtsmeier S, Jun C, Sagona G, et al. α/β-Hydrolase Domain Containing 5 Supports Glucose-Stimulated Lipolysis and Insulin Secretion in Pancreatic β-Cells. Diabetes. 2026;75(8):1411-1423. doi:10.2337/db25-1156
BibTeX
@article{Kim2026,
author = {Kim, Lucy and Liu, Siming and Peachee, Spencer and Richtsmeier, Syreine and Jun, Claudia and Sagona, Gianna and Vikram, Anamika and Freshly, Aidan and Haider, Farakh and Imai, Yumi},
title = {α/β-Hydrolase Domain Containing 5 Supports Glucose-Stimulated Lipolysis and Insulin Secretion in Pancreatic β-Cells},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {8},
pages = {1411--1423},
doi = {10.2337/db25-1156}
}
EUVIMED